Extractables and Leachables Causing Regulatory Delays? E&L Study Strategy
Identifying the early symptoms of E&L problems is essential for timely action. Some common indicators include: Click to read the full article.
Tips for Extractables & Leachables (E&L)
Extractables and Leachables Studies: Practical Roadmap for Pharma Packaging
Identifying the symptoms of potential extractables and leachables issues is the first step toward effective remediation. These symptoms can manifest in various ways during production or in the laboratory:Click to…
How to Design an E&L Risk Assessment for Container Closure Systems
Recognizing early indicators of potential E&L issues is crucial. Here are symptoms to watch for:Click to read the full article.
Extractables vs Leachables: What QA, RA, and Packaging Teams Must Know
Recognizing the symptoms and signals associated with extractables and leachables issues is an essential first step in addressing the problem. Common indicators include:Click to read the full article.
How to Set Analytical Evaluation Thresholds for Leachables Studies
The case began with a routine in-process testing of an injectable pharmaceutical product. Quality Control (QC) analysts noted that the analytical results indicated an elevated level of a specific leachable…
E&L Studies for Injectable Products: High-Risk Packaging Scenarios
Identifying E&L issues starts with recognizing the symptoms that may signal a problem with packaging systems. Common signals on the production floor or in the laboratory may include:Click to read…
Extractables Screening for Elastomer Closures: Common Gaps and Fixes
The initial indicator of potential issues with elastomer closures often appears as discrepancies during stability studies, product testing, or routine quality control measures. Some common symptoms include:Click to read the…
Leachables Monitoring During Stability Studies: How to Build the Protocol
Recognizing signals of potential leachables issues early is essential for mitigation. Key symptoms include:Click to read the full article.
How Packaging Resin Changes Trigger Extractables and Leachables Reassessment
Recognizing the initial signs that indicate a potential issue with extractables and leachables (E&L) is crucial for timely action. Common symptoms include:Click to read the full article.
E&L Risk in Ophthalmic and Otic Multidose Packaging
Detecting issues related to E&L in ophthalmic and otic products can often rely on various signals observed during manufacturing and laboratory testing. In our scenario, the indication that something was…
How to Evaluate Adhesives, Inks, and Labels for Leachable Risk
In pharmaceutical manufacturing, leachables can manifest through various signals that may indicate underlying issues in packaging materials. Common symptoms include:Click to read the full article.
Extractables and Leachables for Prefilled Syringes: Silicone, Tungsten, and Elastomers
Symptoms indicating potential E&L issues may manifest both qualitatively and quantitatively, impacting product quality and safety. Key signals include:Click to read the full article.